Paolo Salerno
-
- Thyroid Cancer Diagnosis and Treatment 11
- Cancer Research top 10%
- Oncology top 10%
- Cancer-related Molecular Pathways 12
-
- Protein Kinase Regulation and GTPase Signaling 3
- DNA Repair Mechanisms 2
- Epigenetics and DNA Methylation 2
- Cell Biology top 10%
-
- Genomics and Rare Diseases 2
- BRCA gene mutations in cancer 2
-
- Cancer Mechanisms and Therapy 2
- Co-authors
- Giuliana SalvatoreMassimo SantoroTito Claudio NappiRosa Marina MelilloValentina De FalcoFulvio BasoloAnna TamburrinoMaria Domenica Castellone
- Journals
- Endocrine Reviews (1 paper)The Journal of Clinical Endocrinology & Metabolism (3 papers)Cancer Research (3 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Paolo Salerno
31 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 89
- Endocrinology, Diabetes and Metabolism 379
- Cancer Research 254
- Oncology 410
- Molecular Biology 667
- Cell Biology 120
Countries citing papers authored by Paolo Salerno
This map shows the geographic impact of Paolo Salerno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Salerno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Salerno more than expected).
Fields of papers citing papers by Paolo Salerno
This network shows the impact of papers produced by Paolo Salerno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Salerno. The network helps show where Paolo Salerno may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paolo Salerno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 7 | |
| 3 | 2021 | 11 | |
| 4 | 2019 | 6 | |
| 5 | 2017 | 12 | |
| 6 | 2014 | 23 | |
| 7 | 2014 | 25 | |
| 8 | 2013 | 97 | |
| 9 | 2012 | 60 | |
| 10 | 2012 | 35 | |
| 11 | 2012 | 58 | |
| 12 | 2011 | 116 | |
| 13 | 2011 | 38 | |
| 14 | 2010 | 35 | |
| 15 | 2009 | 53 | |
| 16 | 2007 | 153 | |
| 17 | Access to and quality of health and social care for rare diseases: patients' and caregivers' experiences. | 2007 | 9 |
| 18 | 2007 | 91 | |
| 19 | [Accessibility and quality to health social services in Italy for the patients with rare diseases: the opinion of associations]. | 2006 | 1 |
| 20 | [Sleep in progressive supranuclear palsy]. | 1984 | 4 |
About Paolo Salerno
Paolo Salerno is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Molecular Biology, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (12 papers), Thyroid Cancer Diagnosis and Treatment (11 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Genomics and Rare Diseases (2 papers), Cancer Mechanisms and Therapy (2 papers), DNA Repair Mechanisms (2 papers), BRCA gene mutations in cancer (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (379 citations), Cancer Research (254 citations) and Oncology (410 citations). Paolo Salerno has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Giuliana Salvatore, Massimo Santoro, Tito Claudio Nappi, Rosa Marina Melillo, Valentina De Falco, Fulvio Basolo, Anna Tamburrino, Maria Domenica Castellone, Massimo Santoro and Francesca Carlomagno. Their work appears in journals such as Endocrine Reviews, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.